Insights

Strategic Partnerships Numab Therapeutics has established key collaborations with leading pharmaceutical companies like Boehringer Ingelheim and Kaken Pharmaceutical, highlighting strong industry relationships and opportunities for joint development and licensing agreements.

Innovative Platform The company's proprietary multispecific antibody platform, incorporating λ-cap™ and MATCH™ technologies, positions it to develop cutting-edge therapeutics, making it an attractive partner for biotech and pharma seeking novel treatment modalities.

Financial Growth Recent capital raises totaling over CHF 230 million demonstrate robust investor confidence and a capacity to fund advanced research and potential clinical trials, creating opportunities for strategic investments or licensing deals.

Therapeutic Focus Numab’s focus on inflammation and oncology with multispecific antibody therapeutics aligns with high-growth, high-demand market segments, suggesting potential for collaborations in unmet medical needs and pipeline expansion.

Leadership & Vision The appointment of a seasoned industry executive as CEO indicates strategic leadership aimed at accelerating growth and partnership opportunities, making the company a compelling candidate for alliances focused on expanding therapeutic applications.

Numab Therapeutics AG Tech Stack

Numab Therapeutics AG uses 8 technology products and services including MODX, Open Graph, jQuery, and more. Explore Numab Therapeutics AG's tech stack below.

MODX

Content Management System

Open Graph

Content Management System

jQuery

Javascript Libraries

Modernizr

Javascript Libraries

Google Maps

Maps

PWA

Miscellaneous

PHP

Programming Languages

Google Tag Manager

Tag Management

Numab Therapeutics AG Email Formats	Example	Percentage
F.Last@numab.com	J.Doe@numab.com	97%
First@numab.com	John@numab.com	3%

Numab Therapeutics AG Email Formats

Example

Percentage

F.Last@numab.com

J.Doe@numab.com

97%

First@numab.com

John@numab.com

Frequently Asked Questions

Where is Numab Therapeutics AG's headquarters located?

Numab Therapeutics AG's main headquarters is located at 5 Bachtobelstrasse Horgen, Zurich 8810 Switzerland. The company has employees across 2 continents, including EuropeNorth America.

What is Numab Therapeutics AG's official website and social media links?

Numab Therapeutics AG's official website is numab.com and has social profiles on LinkedIn Crunchbase.

What is Numab Therapeutics AG's SIC code NAICS code?

Numab Therapeutics AG's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Numab Therapeutics AG have currently?

As of April 2026, Numab Therapeutics AG has approximately 79 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: B. A. P.Ceo: D. U.Chief Business Officer: M. G.. Explore Numab Therapeutics AG's employee directory with LeadIQ.

What industry does Numab Therapeutics AG belong to?

Numab Therapeutics AG operates in the Biotechnology Research industry.

What technology does Numab Therapeutics AG use?

Numab Therapeutics AG's tech stack includes MODXOpen GraphjQueryModernizrGoogle MapsPWAPHPGoogle Tag Manager.

What is Numab Therapeutics AG's email format?

Numab Therapeutics AG's email format typically follows the pattern of F.Last@numab.com. Find more Numab Therapeutics AG email formats with LeadIQ.

How much funding has Numab Therapeutics AG raised to date?

As of April 2026, Numab Therapeutics AG has raised $55M in funding. The last funding round occurred on Jan 09, 2025 for $55M.

When was Numab Therapeutics AG founded?

Numab Therapeutics AG was founded in 2011.

Numab Therapeutics AG

Q: What is Numab Therapeutics AG's official website and social media links?

Numab Therapeutics AG's official website is numab.com. Numab Therapeutics AG has social profiles on LinkedIn.

Q: How many employees does Numab Therapeutics AG have currently?

Numab Therapeutics AG has approximately 79 employees.

Q: What technology does Numab Therapeutics AG use?

Numab Therapeutics AG's tech stack includes Microsoft 365, PHP, Underscore.js, Cloudflare Bot Management, AOS.

Q: What is Numab Therapeutics AG's NAICS code?

Numab Therapeutics AG's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchZurich, Switzerland51-200 Employees

Numab Therapeutics is a biopharmaceutical company focused on the discovery and development of next-generation multispecific antibody-based therapeutics for inflammation and oncology.
With over a decade of innovation, Numab has built a highly differentiated multispecific antibody platform integrating λ-cap™ and MATCH™ technologies, advanced Fc engineering, and integrated immunogenicity-reduction strategies. 
Leveraging deep in-house engineering expertise, Numab is advancing a diversified pipeline of multispecific antibodies with first- and best-in-class potential and has established a strong track record of strategic partnerships with leading pharmaceutical companies.

Insights

Similar companies to Numab Therapeutics AG

Johnson & Johnson

Merus N.V.